DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Dactinomycin
Dactinomycin
Anticancer Drug Discovery from Microbial Sources: the Unique Mangrove Streptomycetes
Cytostatics As Hazardous Chemicals in Healthcare
BC Cancer Benefit Drug List September 2021
Persistent Gestational Trophoblastic Disease Is Potentially Fatal, but the Majority of Patients Are Cured with Chemotherapy
Dactinomycin
Dactinomycin for INJECTION, USP
Pharmaceuticals As Environmental Contaminants
Process for Producing Arsenic Trioxide Formulations
WILMS TUMOUR PI Wilms-1 Protocol
EP/EMA Therapy (Etoposide Cisplatin/Etoposide Methotrexate Dactinomycin)
Standard Oncology Criteria C16154-A
Phase I/II Study of the Mesothelin-Targeted Immunotoxin LMB-100 with Nab-Paclitaxel For
CYTOTOXIC and NON-CYTOTOXIC HAZARDOUS MEDICATIONS
Dactinomycin for Injection) (Actinomycin D
(12) United States Patent (10) Patent No.: US 8,273,379 B2 Warrell, Jr
Antitumor Antibiotics
6. Radiation Recall
EMA/CO Therapy (Etoposide, Methotrexate, Dactinomycin, Cyclophosphamide, Vincristine)
Top View
2012 NIOSH List of Antineoplastic and Other Hazardous Drugs
Pharmacokinetics of Dactinomycin in a Pediatric Patient Population: a United Kingdom Children’S Cancer Study Group Study Gareth J
BC Cancer Protocol Summary for Adjuvant Therapy for Rhabdomyosarcoma Using Vincristine, Dactinomycin, and Cyclophosphamide
GOTDMR Protocol
VACA (Vincristine Dactinomycin Doxorubicin Cyclophosphamide)
Chemotherapy Extravasation Management
2019 Table of Drugs
Types of DRUGS ACTING on DNA (In Chapter 9) Intercalating Agents
Safe Handling of Hazardous Chemotherapy Drugs in Limited-Resource Settings
How to Order Chemotherapy at Shands at the University of Florida - Inpatient
Vincristine, Dactinomycin, Cyclophosphamide
COSMEGEN (Dactinomycin) MB1904
Dactinomycin-D Richard J. Cardosi, MD, FACOG
Management of Gestational Trophoblastic Neoplasia Ansar Hussain*, Shiekh Aejaz Aziz, Gul Mohd
Management of Extravasation of a Systemic Anti-Cancer Therapy Including Cytotoxic Agents
Handling Cytostatic Drugs: Contents
Update in Cancer Chemotherapy: Genitourinary Tract Cancer, Part 4: Testicular Cancer
Dactinomycin Induces Complete Remission Associated with Nucleolar Stress Response in Relapsed/Refractory NPM1-Mutated AML